Detalhe da pesquisa
1.
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
Prostate
; 84(3): 292-302, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964482
2.
The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care.
Genet Med
; 23(6): 1086-1094, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33654192
3.
An appraisal of genetic testing for prostate cancer susceptibility.
NPJ Precis Oncol
; 6(1): 43, 2022 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732815
4.
Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada.
Can Urol Assoc J
; 16(10): 321-332, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240332
5.
The evolving role of germline genetic testing and management in prostate cancer: Report from the Princess Margaret Cancer Centre international retreat.
Can Urol Assoc J
; 15(12): E623-E629, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171218
6.
Development of patient "profiles" to tailor counseling for incidental genomic sequencing results.
Eur J Hum Genet
; 27(7): 1008-1017, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846854
7.
"Guys Don't Have Breasts": The Lived Experience of Men Who Have BRCA Gene Mutations and Are at Risk for Male Breast Cancer.
Am J Mens Health
; 12(4): 961-972, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29400121